Pfizer (PFE) Dividend Coverage Ratio Growth (1y) (2010 - 2026)
Powered by 
Analysis
Pfizer (PFE) Dividend Coverage Ratio Growth (1y) (2010 - 2026) Analysis & Trends
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Div. Cover Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 644.71 Bn | 623.96 Bn | 17.26 Bn | -3.09% |
| 2 | AbbVie | 440.73 Bn | 434.16 Bn | 12.70 Bn | 264.24% |
| 3 | Merck | 365.57 Bn | 358.43 Bn | 12.21 Bn | -129.25% |
| 4 | Novartis Ag | 266.81 Bn | 259.12 Bn | 11.24 Bn | -30.09% |
| 5 | Pfizer | 159.17 Bn | 147.47 Bn | 10.94 Bn | -108.11% |
| 6 | Sanofi | 52.46 Bn | 45.08 Bn | 10.79 Bn | -92.21% |
| 7 | Revolution Medicines | 44.24 Bn | 44.24 Bn | - | - |
| 8 | Incyte | 25.37 Bn | 20.83 Bn | 1.57 Bn | - |
| 9 | United Therapeutics | 21.48 Bn | 18.82 Bn | 683.80 Mn | - |
| 10 | Neurocrine Biosciences | 15.55 Bn | 15.16 Bn | 935.80 Mn | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 28, 2026 | -108.11% |
| Mar 29, 2026 | -9.64% |
| Sep 28, 2025 | 35.74% |
| Jun 29, 2025 | 5,837.83% |
| Mar 30, 2025 | -7.31% |
| Jun 30, 2024 | -98.00% |
| Mar 31, 2024 | -45.43% |
| Jul 2, 2023 | -77.13% |
| Apr 2, 2023 | -31.05% |
| Jul 3, 2022 | 72.48% |
| Apr 3, 2022 | 55.57% |
| Oct 3, 2021 | 116.23% |
| Jul 4, 2021 | 54.58% |
| Apr 4, 2021 | 40.73% |
| Sep 27, 2020 | -65.64% |
| Jun 28, 2020 | -34.41% |
| Mar 29, 2020 | -15.99% |
| Dec 31, 2019 | -47.17% |
| Sep 29, 2019 | 85.48% |
| Jun 30, 2019 | 29.50% |